How quickly does Wegovy make you nauseous — and what does the evidence say?

Nausea most commonly starts within 24–72 hours of a new dose or dose increase, and tends to be at its worst in the first week of each new level.
In the STEP 1 trial, nausea was reported by roughly 44% of people on the 2.4mg dose, but for the majority it was mild to moderate and settled over days to weeks.
The slow dose-escalation schedule (starting at 0.25mg and titrating upward over several months) is specifically designed to reduce the intensity and frequency of GI side effects.
Persistent, severe or worsening stomach pain (especially pain that reaches the back) is different from ordinary nausea and needs urgent medical attention; report any suspected side effects at the MHRA Yellow Card scheme.

Nausea from Wegovy (semaglutide) typically begins within the first day or two after your first injection, with most people noticing it most sharply in the 24 to 72 hours that follow a new dose or a dose increase. Clinical trial data from the STEP 1 study, published in the New England Journal of Medicine, recorded nausea as the single most common side effect — affecting around 44% of participants on the 2.4mg maintenance dose, compared with about 16% on placebo. These are prescription-only medicines; whether semaglutide is clinically suitable for you is a decision made by a prescriber following a proper assessment, not something that can be determined from a side-effect profile alone.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

When nausea hits, how long it lasts, and what the trial data tells us

What the STEP 1 trial data actually shows about timing

The STEP 1 trial enrolled 1,961 adults and tracked side effects across 68 weeks of treatment. Nausea clustered heavily in the early weeks at each dose level, it was not a sustained, constant feature for most participants. The data showed rates of nausea falling noticeably after the first few weeks at a given dose, which fits with what we know about how the body adapts to GLP-1 receptor stimulation. When the prescriber increased the dose, a second wave of nausea was common, again peaking in the first 24–72 hours and then subsiding. This pattern repeats through the titration steps: 0.25mg, then 0.5mg, then 1.0mg, then 1.7mg, building to the 2.4mg maintenance dose over approximately five months. The gradual climb is not incidental, it is the mechanism by which most people avoid the worst of the GI effects.

If you want a broader picture of how quickly the medicine itself starts working beyond nausea, our page on how quickly Wegovy works covers appetite changes and early effects separately.

Why your stomach reacts the way it does

Semaglutide acts on GLP-1 receptors in the gut as well as the brain. One effect is a significant slowing of gastric emptying, food sits in the stomach for longer. That is part of why appetite falls and portion tolerance drops, but it is also directly responsible for the nausea, bloating and fullness that people notice in the early weeks. The brain's chemoreceptor trigger zone, which governs the vomiting reflex, also carries GLP-1 receptors; direct stimulation there contributes to queasiness independently of what is happening in the stomach itself.

A question our prescribers hear most weeks is whether nausea means the medicine is working. The honest answer is that nausea is a sign of GLP-1 activity, not a marker of efficacy on its own, people who experience minimal nausea can still see meaningful results, and people who feel very sick are not necessarily losing weight faster. As the NHS semaglutide patient page notes, GI side effects are a known and expected part of starting treatment, and most people do not need to stop because of them.

Factors that influence how quickly and strongly nausea hits

Not everyone experiences nausea at the same intensity or on the same timeline. Several things appear to make early nausea more pronounced: eating large meals, eating quickly, lying down soon after eating, and consuming fatty or very rich food. These are practical rather than clinical adjustments, smaller meals spaced through the day, eating slowly and staying upright for an hour or so after food can make a real difference. Hydration matters too; nausea on a nearly-empty stomach with too little fluid tends to feel worse. Alcohol can amplify GI discomfort in the early weeks and is worth limiting. None of these are formal prescriber instructions, for anything specific to your dose and situation, the prescriber and the Patient Information Leaflet are the right sources.

Individual biology also plays a part. People with a history of motion sickness or GI sensitivity tend to report earlier and stronger nausea. Starting at the lowest dose gives the gut the best chance to adjust, which is exactly why the titration schedule exists. If you are thinking about what to expect in the weeks ahead, our page on how long nausea typically lasts on Wegovy covers duration in more detail.

When nausea is a signal to seek medical help

Ordinary early nausea (queasy, off food, occasionally sick) is expected and usually settles within days at each dose level. But certain symptoms warrant prompt medical attention and should not be waited out. Severe, persistent stomach pain that radiates toward the back, with or without vomiting, can indicate acute pancreatitis; this is an infrequent but serious risk that the MHRA highlighted in a Drug Safety Update in January 2026 specifically covering GLP-1 medicines. Stop and seek urgent help if that pattern appears. Similarly, vomiting that is severe enough to prevent you keeping fluids down raises the risk of dehydration, which can itself cause kidney strain, if you cannot stay hydrated, contact a healthcare professional rather than pushing through. Signs of an allergic reaction (facial swelling, difficulty breathing, rapid heartbeat alongside nausea) also need emergency attention.

For anyone tracking early results alongside these early side effects, the evidence on how quickly weight loss begins on Wegovy gives a realistic timeline grounded in the trial data. People often have related questions at this stage, including how quickly you feel Wegovy's effects in the first place and, looking at the same question from a slightly different angle, how quickly Wegovy takes effect overall, both of which are worth reading together. The cost of a private prescription is one practical consideration; our page on Wegovy pricing in the UK sets out what is typically included in a legitimate private prescription service.

If you would like to discuss whether Wegovy is a suitable option for you, start your free consultation with our prescribers, same-day clinical review, no waiting list.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions